Form 4: Candel Therapeutics Chief Scientific Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Francesca Barone, Chief Scientific Officer of Candel Therapeutics, sold 13,673 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Francesca Barone, the Chief Scientific Officer of Candel Therapeutics, sold 13,673 shares of common stock on January 8, 2025.
- The sale was executed at a price of $8.2182 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted stock units, as per the Issuer's mandatory sell-to-cover policy.
- Following the transaction, Barone directly owns 124,207 shares of Candel Therapeutics.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales to cover tax obligations are a common practice among executives receiving equity compensation. This transaction reflects standard compensation practices and tax regulations.
Key Dates
| Date | Description |
|---|---|
| 01/08/2025 | Date of stock sale transaction |
| 01/10/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.